ArticleTherapeutic advances in respiratory disease

Acquired multiple mutations ALK I1171N, L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report.

Jia Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.